(Q86048407)

English

A modified filgrastim regimen does not reduce pain burden compared to pegfilgrastim in women receiving chemotherapy for non-metastatic breast cancer

scientific article published on 26 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A modified filgrastim regimen does not reduce pain burden compared to pegfilgrastim in women receiving chemotherapy for non-metastatic breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

non-metastatic breast cancer

1 reference

based on heuristic

inferred from title

author name string

Mova Leung

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Joy Florendo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jessica Kano

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Tiffany Marr-Del Monte

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Brian Higgins

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Robert Myers

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Trishala Menon

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Glenn Jones

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

26 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1669-1677

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

https://scigraph.springernature.com/pub.10.1007/s00520-014-2449-z

0 references

Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-a retrospective analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Responsiveness of the numeric pain rating scale in patients with low back pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of febrile neutropenia during adjuvant chemotherapy for breast cancer: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of filgrastim and pegfilgrastim to support delivery of chemotherapy: twenty years of clinical experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3-4 week chemotherapy regimens in community oncology practices.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain--results of the LEARN Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone pain associated with once-per-cycle pegfilgrastim is similar to daily filgrastim in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxanes for adjuvant treatment of early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel-related side effects and their management

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statistics review 4: sample size calculations

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results

1 reference

https://pubmed.ncbi.nlm.nih.gov/25421443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-014-2449-Z

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421443%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q86048407&oldid=1497136376"